Long-term treatment effects of insulin pump therapy

Practical Diabetes

Volumn 28, Issue 7, 2011, Pages 295-299a

  Garmo, Anna ^a,b,e   Garmo, Hans ^c   Ärnlöv, Johan ^b,d   Leksell, Janeth ^b,d  

^a FALUN HOSPITAL   (Sweden)

^b DALARNA UNIVERSITY   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UPPSALA UNIVERSITY   (Sweden)

^e Diabetes endokrinmottagningen   (Sweden)

Author keywords

Continuous subcutaneous insulin infusion; Glycaemic control; Multiple daily insulin injections; Treatment satisfaction; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BRADLEY DIABETES TREATMENT SATISFACTION QUESTIONNAIRE; CLINICAL ARTICLE; CONTINUOUS INFUSION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LONG TERM CARE; MALE; PATIENT SATISFACTION; QUESTIONNAIRE;

EID: 84859764786     PISSN: None     EISSN: 20472900     Source Type: Journal    
DOI: 10.1002/pdi.1618     Document Type: Article

References (32)

1. Weissberg-Benchell J, et al. Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26:1079-87. (Pubitemid 36929252)
2. Jeitler K, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008;51:941-51.
3. Pickup J, et al. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002;324:705.
4. Pickup JC, Renard E. Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 2008;31 (Suppl 2):S140-5.
5. A Desktop Guide to Type 1 (Insulin-dependent) Diabetes Mellitus: European Diabetes Policy Group 1998, International Diabetes Federation, European Region. Exp Clin Endocrinol Diabetes 1998; 106:240-69.
6. A desktop guide to type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med 1999;16:716-30.
7. Bradley C, Gamsu DS. Guidelines for encouraging psychological well-being: report of a Working Group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med 1994;11:510-6.
8. Lewis KS, et al. Measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabet Med 1988;5:235-42.
9. Bradley C. The Diabetes Treatment Satisfaction Questionnaire DTSQ. In Handbook of Psychology and Diabetes: a guide to psychological measurement in diabetes research and practice. Bradley C (ed). Chur, Switzerland: Harwood Academic Publishers, 1994.
10. Bradley C. On calculating treatment satisfaction. Diabetes Care 1999;22:1760.
11. Wredling R, et al. Well-being and treatment satisfaction in adults with diabetes: a Swedish population- based study. Qual Life Res 1995;4:515-22.
12. Ihaka R, Gentleman R. R: A language for data analysis and graphics. J Computational Graphical Statistics 1996;5:299-314.
13. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
14. Reichard P, et al. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-9. (Pubitemid 23210681)
15. Bolli GB, et al. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study. Diabetes Care 2009;32:1170-6.
16. Hanaire H, et al. Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab 2008;34:401-23.
17. Bruttomesso D, et al. Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabet Med 2002;19:628-34. (Pubitemid 34985162)
18. Hsu SR, et al. Metabolic control with insulin pump therapy: preliminary experience. J Chin Med Assoc 2008;71:353-6.
19. Linkeschova R, et al. Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002;19:746-51. (Pubitemid 35013853)
20. Reda E, et al. Metabolic control with insulin pump therapy: the Waikato experience. N Z Med J 2007;120:U2401.
21. Olsovsky J, Beranek M. The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI). Vnitr Lek 2007;53:637-45. (Pubitemid 46997691)
22. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 1996;19:195-203.
23. Barnard KD, et al. Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes. Diabet Med 2007;24:607-17. (Pubitemid 46808863)
24. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999;15:205-18. (Pubitemid 29359038)
25. Bradley C, et al. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ. Health Qual Life Outcomes 2007;5:57.
26. Garmo A, et al. Treatment effects and satisfaction in diabetic patients changing from multiple daily injections to CSII. Pract Diabetes Int 2004;21: 7-12. (Pubitemid 38248087)
27. Johansson U-B. Insulinbehandling vid typ 1 diabetes. Norstedts Tryckeri AB, Stockholm, 2000.
28. Nicolucci A, et al. Quality of life and treatment satisfaction in adults with type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med 2008;25:213-20. (Pubitemid 351293404)
29. Saunders SA, et al. Glycaemic control in a type 1 diabetes clinic for younger adults. QJM 2004;97:575-80. (Pubitemid 39214324)
30. Wikblad K, et al. Health-related quality of life in relation to metabolic control and late complications in patients with insulin dependent diabetes mellitus. Qual Life Res 1996;5:123-30. (Pubitemid 26100510)
31. Adair JG. The Hawthorne effect: a reconsideration of the methodological artifact. J Appl Psychol 1984;69:334-5.
32. Nordin G. HbA1c med enheten mmol/mol. DiabetologNytt SFD 2010;23(1):11-24.